Myriad Genetics - 株価

MYGN

30.21

毎日の変更:

0.37%

毎年:

68.49%

価格 日 年
Agilent 122.10 -2.92 -2.34% 56.32%
Accelerate Diagnostics 10.29 -1.21 -10.52% -28.14%
Becton, Dickinson and Co. 247.15 0.44 0.18% 0.41%
Bio-Rad Laboratories 582.45 -12.29 -2.07% 57.85%
Biocept 6.24 -0.42 -6.31% 1,912.90%
Bruker 62.79 -1.47 -2.29% 35.85%
Quest Diagnostics 114.63 -1.11 -0.96% 4.28%
Danaher 219.26 -3.74 -1.68% 44.07%
Exact Sciences 131.30 -3.52 -2.61% 62.58%
Fluidigm 4.82 -0.19 -3.70% 43.88%
GenMark Diagnostics 18.80 -0.49 -2.54% 416.48%
Hologic 72.36 -2.79 -3.71% 49.07%
Illumina 445.86 -15.19 -3.29% 62.31%
Johnson & Johnson 162.76 0.17 0.10% 13.28%
Luminex 32.99 2.94 9.78% 41.89%
Mettler Toledo International 1,109.91 -17.69 -1.57% 58.47%
Myriad Genetics 30.21 0.11 0.37% 68.49%
NanoString Technologies 70.64 -4.83 -6.40% 115.50%
OraSure Technologies 10.69 -0.16 -1.47% 76.40%
Oxford Immunotec Global 21.92 -0.01 -0.05% 60.70%
Pacific Biosciences Of California 31.18 -4.58 -12.80% 822.34%
PerkinElmer 125.97 -2.81 -2.18% 46.48%
Quidel 166.15 -5.98 -3.47% 105.28%
Repligen 207.07 -8.51 -3.95% 143.15%
Thermo Fisher Scientific 451.47 -5.19 -1.14% 46.03%
Veracyte 58.56 -3.74 -6.00% 151.76%
Waters 278.23 -1.67 -0.60% 37.33%

価格 日 年
NASDAQ 13119 -478.54 -3.52% 46.08%

MYGN:US
資産
現金と同等
売上原価
流動資産
流動負債
負債
EBIT
EBITDA
従業員
株当たりのEPS利益
自己資本および準備金
売上総利益
債務の支払利息
借入資本
時価総額
当期純利益
営業経費
営業利益
普通株資本
税引前利益
販売収入
販売および管理費
株式
貿易債権者
貿易債務者